نتائج البحث - Nazanin Fallah‐Rad

  • يعرض 1 - 4 نتائج من 4
تنقيح النتائج
  1. 1
    Delayed contrast enhancement cardiac magnetic resonance imaging in trastuzumab induced cardiomyopathy

    Delayed contrast enhancement cardiac magnetic resonance imaging in trastuzumab induced cardiomyopathy حسب Nazanin Fallah‐Rad, Matthew Lytwyn, Tielan Fang, Iain Kirkpatrick, Davinder S. Jassal

    منشور في 2008
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Impact of the COVID-19 Pandemic on the Wellbeing of International Oncology and Hematology Fellows at the Princess Margaret Cancer Center (PMCC)

    Impact of the COVID-19 Pandemic on the Wellbeing of International Oncology and Hematology Fellows at the Princess Margaret Cancer Center (PMCC) حسب Carlos Stecca, Marie Alt, Di Jiang, Glaucia Michelis, Nazanin Fallah‐Rad, Sharlene Gill, Mary Elliot, Srikala S. Sridhar

    منشور في 2022
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    The Utility of Cardiac Biomarkers, Tissue Velocity and Strain Imaging, and Cardiac Magnetic Resonance Imaging in Predicting Early Left Ventricular Dysfunction in Patients With Human Epidermal Growth Factor Receptor II–Positive Breast Cancer Treated With Adjuvant Trastuzumab Therapy

    The Utility of Cardiac Biomarkers, Tissue Velocity and Strain Imaging, and Cardiac Magnetic Resonance Imaging in Predicting Early Left Ventricular Dysfunction in Patients With Huma... حسب Nazanin Fallah‐Rad, Jonathan R. Walker, Anthony Wassef, Matthew Lytwyn, Sheena Bohonis, Tielan Fang, Ganhong Tian, Iain D.C. Kirkpatrick, Pawan K. Singal, Marianne Krahn, Debjani Grenier, Davinder S. Jassal

    منشور في 2011
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Real-World Efficacy and Toxicity of Ipilimumab and Nivolumab as First-Line Treatment of Metastatic Renal Cell Carcinoma (mRCC) in a Subpopulation of Elderly and Poor Performance Status Patients

    Real-World Efficacy and Toxicity of Ipilimumab and Nivolumab as First-Line Treatment of Metastatic Renal Cell Carcinoma (mRCC) in a Subpopulation of Elderly and Poor Performance St... حسب Noa Shani Shrem, Ana-Alicia Beltran-Bless, Sunita Ghosh, Camilla Tajzler, Lori Wood, C. Kollmannsberger, Naveen S. Basappa, Jeffrey Graham, Nazanin Fallah‐Rad, Daniel Yick Chin Heng, Denis Soulières, Aly‐Khan A. Lalani, Rodney H. Breau, Antonio Finelli, Simon Tanguay, Bimal Bhindi, Georg A. Bjarnason, Frédéric Pouliot, Christina Canil

    منشور في 2025
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: